pn 401 has been researched along with phosphocreatine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bolo, NR; Cohen, BM; Daniels, M; Haws, C; Jensen, JE; Lyoo, IK; Renshaw, PF; Rusche, JR; Stoll, AL; Yoon, SJ | 1 |
1 trial(s) available for pn 401 and phosphocreatine
Article | Year |
---|---|
Triacetyluridine (TAU) decreases depressive symptoms and increases brain pH in bipolar patients.
Topics: Acetates; Adult; Antidepressive Agents; Bipolar Disorder; Brain Chemistry; Depressive Disorder; Female; Humans; Hydrogen-Ion Concentration; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Mitochondria; Neuropsychological Tests; Phosphocreatine; Psychiatric Status Rating Scales; Uridine | 2008 |